Patterns of antibiotics sensitivity in culture positive cases of urinary tract infections in children.
DOI:
https://doi.org/10.29309/TPMJ/2023.30.11.7656Keywords:
Urinary Tract Infection, Antibiotic Sensitivity, Uropathogens, Narrow Spectrum AntibioticsAbstract
Objective: To determine the effective narrow spectrum antibiotics for treatment of UTI in children in order to control the rapidly increasing antibiotic resistance to broad spectrum antibiotics. Study Design: Prospective Clinical study. Setting: Department of Pediatric, Akbar Niazi Teaching Hospital, Bhara Kahu-Pakistan. Period: January 2021 to December 2021. Material & Methods: 361 children with clinical suspicion of UTI Urine samples were collected. Antimicrobial sensitivity test was applied on Samples on which bacterial growth was identified using Clinical Laboratory Standards Institute (CLSI) guidelines. The data was analyzed using SPSS version 25. Results: Total 361 patients were enrolled in the study according to inclusion criteria, out of which, 30 (8.3%) were infants (<1 years old), 178 (49.3%) were aged 1 to 5 years and 153 (42.4%) were aged from 5 to 12 years of age. Out of 361 patients, 125 (34.6%) patients were males and 236 (65.4%) were females. Out of 124 patients, whose urine culture was positive, most common pathogen was E. coli that was observed in 92 (25.5%) cases, followed by Klebsialla in 9 (2.5%) and enterococcus in 9 (2.5%) patients, Pseudomonas in 5 (1.4%), Proteus in 4 (1.1%), Mirabilis in 4 (1.1%), Acinobacter in 2 (0.6%), and enterobacter in 2 (0.6%) cases. Spectrum of sensitivity of 17 drugs was studied. The most sensitive drug was Imipenem, (29.9%), followed by Nitrofurantoin, Fosfomycin (25.8%), Amikacin (24.1%), Piperacilin / Tazobactam (22.7%). Conclusion: Thus E. coli was the most common pathogen and the most sensitive drug was Imipenem, followed by Nitrofurantoin, Fosfomycin, Amikacin, and Piperacilin / Tazobactam.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 The Professional Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.